Effective Use of In-Silico Tools in Lead Optimization
Poster Sep 20, 2011
Pranas Japertas, Andrius Sazonovas and Kiril Lanevskij
Physicochemical profiling is carried out very early to get a jump-start in the drug discovery process. Even during hit-to-lead and lead optimization many individuals are involved in the determination of these properties to keep projects focused on molecules that are more likely to be good drug candidates. The advent of various in silico techniques has led many to believe these methods would become the ‘holy grail’ of the future drug discovery. However, despite constant advances in the field and the huge number of available models enabling predictions of a multitude of properties, computational approaches in general still fail to meet high initial expectations. A rational approach to computer-aided lead optimization should involve a variety of techniques including predictions of ADME/Tox properties with a mechanistic insight, and routines that address other issues associated with the compound’s suitability for use as a drug.
Exploiting Polypharmacology in Precision Oncology: Identification of Differential Kinase Off-targets Among Clinical PARP InhibitorsPoster
Can we use computational methods to identify previously unknown off-targets of PARP inhibitors that can explain their observed differences?READ MORE
NanoBRET™ Assays for Monitoring Protein Interactions in Living CellsPoster
NanoBRET PPI System is composed of two components.
NanoBRET offers improved S:B over other BRET assays.
NanoBRET provides sensitive live-cell method to study protein interactions.
Human iPSC-derived cardiomyocytes: A translational model to predict drug-induced cardiac arrhythmias and long-term toxicityPoster
The results shown here imply that iPSC-derived Cor.4U human cardioymocytes are a translational in vitro cell model for the prediction of clinically relevant drug-induced cardiac arrhythmias and long-term toxicity.READ MORE